logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Institute for Pulmonary Diseases of Vojvodina

+381214805100
ipbvojvodine@gmail.com
Source: Site record.
http://www.ipb-ild.edu.rs

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

The Institute for Pulmonary Diseases of Vojvodina (ipb-ild.edu.rs) is a specialized tertiary-care academic center dedicated to respiratory and pulmonary diseases, with strong relevance for clinical research in pulmonology, oncology, and infectious diseases. Located in Sremska Kamenica, the institute integrates clinical care, education, and scientific research, supported by multiple specialized clinics including obstructive lung diseases, interstitial and granulomatous diseases, pulmonary oncology, thoracic surgery, and emergency pulmonology.

Business Status

Source: Google. OPEN

Business Category

Source: Google. Specialized clinic

Business Subcategory

Source: Google. Specialized clinic
Source: Trial-derived.
44Total Trials
Source: Trial-derived.
4Recruiting Trials
Source: Trial-derived.
14Active Trials
Source: Trial-derived.
23Completed Trials
Source: Trial-derived.
54Unique Conditions
Source: Trial-derived.
33Unique Sponsors

Conditions

Source: Trial-derived. Pulmonary Arterial Hypertension (6)Source: Trial-derived. Small Cell Lung Cancer (5)Source: Trial-derived. Non-Small Cell Lung Cancer (4)Source: Trial-derived. Idiopathic Pulmonary Fibrosis (3)Source: Trial-derived. Cardiovascular Diseases (2)Source: Trial-derived. Connective Tissue Diseases (2)Source: Trial-derived. Familial Primary Pulmonary Hypertension (2)Source: Trial-derived. Hypertension (2)

Sponsors

Source: Trial-derived. Hoffmann-La Roche (6)Source: Trial-derived. AbbVie (4)Source: Trial-derived. Actelion (2)Source: Trial-derived. Amgen (2)Source: Trial-derived. Boehringer Ingelheim (2)Source: Trial-derived. Chiesi Farmaceutici S.p.A. (2)Source: Trial-derived. Connect Biopharm LLC (2)Source: Trial-derived. Incyte Corporation (2)

Facilities & Operations

Facilities and operational capabilities inferred from trial participation

Source: AI-inferred. Overnight or inpatient research stays supported

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. CT Scan
Source: AI-inferred. Spirometry
Source: AI-inferred. Six-minute walk test
Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. Full pulmonary function lab (DLCO / plethysmography)
Source: AI-inferred. MRI

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Circulating tumour DNA testing

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling
Source: AI-inferred. Sterile preparation (laminar-flow hood / BSC or cleanroom)

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Cardiac catheterisation or electrophysiology procedures
Source: AI-inferred. Intensive care (ICU)

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Accelerometer-based physical activity monitoring
Source: AI-inferred. Brain imaging
Source: AI-inferred. Electronic participant diary (e-diary) system
Source: AI-inferred. Electronic patient-reported outcome (ePRO) tablet collection
Source: AI-inferred. Immunohistochemistry (IHC) biomarker testing
Source: AI-inferred. Nebulised study drug administration
Source: AI-inferred. Pulmonary function testing
Source: AI-inferred. Supplemental oxygen therapy